VANGUARD GROUP INC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,121,009
+5.5%
1,020,317
+1.0%
0.00%
Q2 2023$15,287,599
+13.5%
1,009,749
+8.7%
0.00%
Q1 2023$13,465,642
+8.2%
928,665
+0.9%
0.00%
Q4 2022$12,441,821
-9.3%
920,253
+5.8%
0.00%
Q3 2022$13,714,000
+47.7%
870,147
+14.1%
0.00%
Q2 2022$9,285,000
+129.8%
762,364
+77.1%
0.00%
Q1 2022$4,041,000
-44.4%
430,404
+1.3%
0.00%
Q4 2021$7,274,000424,9520.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders